Reshape ApS: Financial statements 2025
CVR: 40056173
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
Reshape ApS (CVR 40056173) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,603,206 and a net result of DKK -35,557,856 compared with DKK -12,222,020 the year before. That is an increase of 281.9% compared with the year before. Equity in the 2025 report amounted to DKK 36,562,988. The solvency ratio was 83.6%. The company had 51 employees in the financial year.
- Gross Profit
- DKK 6,603,206
- Profit/Loss
- DKK -35,557,856
- Equity
- DKK 36,562,988
- Total Assets
- DKK 43,713,434
- Employees
- 51
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6.6 mio. | -35.6 mio. | 36.6 mio. | 51 |
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
| 2021 | - | 593 t. | 52 t. | 1.3 mio. | 7 |
Official annual report
How creditworthy is Reshape ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Carl-Emil Grøn Fuglesang, Daniel Storgaard and Magnus Nyborg Madsen. The company is owned by Reshape Biotech Inc.. According to the 2026 annual report, the company had an average of 56 employees. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity in the 2026 report amounted to DKK 75,515,117.